CRGX vs. RLAY, TYRA, ANAB, KURA, CRMD, ABUS, PHAR, IMTX, ORIC, and RAPP
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Relay Therapeutics (RLAY), Tyra Biosciences (TYRA), AnaptysBio (ANAB), Kura Oncology (KURA), CorMedix (CRMD), Arbutus Biopharma (ABUS), Pharming Group (PHAR), Immatics (IMTX), ORIC Pharmaceuticals (ORIC), and Rapport Therapeutics (RAPP). These companies are all part of the "pharmaceutical products" industry.
CARGO Therapeutics vs.
CARGO Therapeutics (NASDAQ:CRGX) and Relay Therapeutics (NASDAQ:RLAY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 97.0% of Relay Therapeutics shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by company insiders. Comparatively, 4.3% of Relay Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
CARGO Therapeutics currently has a consensus target price of $15.00, indicating a potential upside of 297.88%. Relay Therapeutics has a consensus target price of $20.50, indicating a potential upside of 422.96%. Given Relay Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Relay Therapeutics is more favorable than CARGO Therapeutics.
CARGO Therapeutics has higher earnings, but lower revenue than Relay Therapeutics. Relay Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Relay Therapeutics had 1 more articles in the media than CARGO Therapeutics. MarketBeat recorded 4 mentions for Relay Therapeutics and 3 mentions for CARGO Therapeutics. Relay Therapeutics' average media sentiment score of 1.07 beat CARGO Therapeutics' score of 0.02 indicating that Relay Therapeutics is being referred to more favorably in the news media.
Relay Therapeutics received 45 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 69.41% of users gave Relay Therapeutics an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote.
CARGO Therapeutics' return on equity of -38.16% beat Relay Therapeutics' return on equity.
CARGO Therapeutics has a beta of 2.07, meaning that its share price is 107% more volatile than the S&P 500. Comparatively, Relay Therapeutics has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500.
Summary
Relay Therapeutics beats CARGO Therapeutics on 11 of the 16 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:CRGX) was last updated on 2/22/2025 by MarketBeat.com Staff
Free CRGX Stock Alerts